← Open Payments lookup

SPENCER STANGER: Open Payments

NPI 1780194696 · RIGBY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 45 payments from 21 companies in 2025. Trend: 2023 $415 · 2024 $1,125 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
ABBVIE INC.12$179
Vanda Pharmaceuticals Inc.4$105
Lilly USA, LLC5$76
Neuronetics, Inc.1$57
Novo Nordisk Inc3$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Axsome Therapeutics, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Phathom Pharmaceuticals, Inc.2$35
Astellas Pharma US Inc1$34

Products named: VRAYLAR, FANAPT, MOUNJARO, NEUROSTAR TMS THERAPY SYSTEM, UBRELVY, CAPLYTA, Auvelity, XIFAXAN.

Industry payments across ID — which companies pay providers there.